How Guy’s and St Thomas’ Is Using AI to Shape the Future of Radiotherapy

Dr. Teresa Guerrero Urbano is a Consultant Clinical Oncologist (Head and Neck, Prostate and Non Melanomatous Skin Cancer) and Adjunct Reader at Guy’s and St Thomas NHS Trust and King’s College London. She has a special interest in the evaluation of AI in radiotherapy, prioritising the development of predictive models of toxicity and tumour outcomes that could then be used to further inform treatment adaptation through intensification or de-intensification strategies as well as the clinical translation of AI models into the clinic. Additional research interests and expertise focus on molecular and imaging biomarkers of radioresistance in HNC with the use of functional imaging to guide adaptive radiotherapy (RT) to overcome said radioresistance. She is a recognized national and international expert in the fields of Head and Neck Cancer and applications of AI in radiotherapy (European Society of Therapeutic Radiation Oncology Head and Neck focus group core member and National Institute Clinical Excellence reviewer on the role of AI tools in Radiotherapy). Additional roles include leading Radiotherapy Development for Guy’s and St Thomas NHS Trust, Clinical Lead of the South East London and Kent and Medway Radiotherapy Clinical Network and member of the Radiotherapy National Clinical Reference group. She is actively involved in clinical trials as well as teaching and training, public education and patient and public involvement.

Anil Mistry is the project lead for AI software applications developed by the Clinical Scientific Computing (CSC) team at Guy’s and St Thomas’ NHS Foundation Trust , and is a project manager on the evaluation, installation and deployment of commercial AI software and platforms into routine clinical care. He also leads the regulatory aspects of the CSC, notably on the development of the Quality Management System towards ISO134835 compliance for Safe development of Software as a Medical Device (SaMD).

Craig Rhodes is a Senior Leader at the intersection of technology and healthcare, currently serving as Director of Strategic Partnerships at deepc. He focuses on leveraging AI and data analytics to address healthcare challenges, improve patient outcomes, and integrate ethical AI into clinical workflows. His expertise includes predictive modelling, digital health scaling, and fostering collaborations between providers and innovators. Previously, Craig led AI initiatives at NVIDIA, driving advancements in drug discovery, clinical practice, and personalized medicine. He supported deploying AI in radiology, pathology, genomics, and natural language processing while enabling the use of supercomputing facilities like the UK’s largest supercomputer. Recognized internationally, Craig actively shapes strategies for adopting emerging medical technologies responsibly.